Related Experiment Video
Updated: May 21, 2026
04:05
A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function
Published on: October 6, 2023
Serum thyroid hormone profile and trace elements in children receiving valproic acid therapy: a longitudinal and
Hakan Doneray1, Ilknur Surucu Kara, Akar Karakoc
1Department of Pediatric Endocrinology, Ataturk University, Erzurum, Turkey. hdoneray@hotmail.com
Summary
Valproic acid (VPA) therapy in children may lower copper levels, potentially impacting thyroid function. This study found reduced copper, increased TSH, and decreased FT4 during VPA treatment.
Area of Science:
- Pediatric Endocrinology
- Neuropharmacology
- Clinical Chemistry
Background:
- Valproic acid (VPA) is commonly used for epilepsy and bipolar disorder.
- VPA has been anecdotally linked to thyroid dysfunction and altered trace element levels.
- The specific impact of VPA monotherapy on thyroid hormone profile and trace elements in children requires further investigation.
Purpose of the Study:
- To prospectively investigate the relationship between VPA monotherapy and thyroid hormone and serum trace element concentrations in children.
- To evaluate changes in thyrotropin (TSH), free thyroxine (FT4), thyroxine (T4), and trace elements like copper (Cu) over a 6-month period.
Main Methods:
- Prospective study involving children on VPA monotherapy and a control group.
- Measurement of serum TSH, FT4, FT3, T4, T3, TG, Se, Zn, and Cu at baseline and 6 months.
- Statistical analysis to compare patient and control groups and assess correlations.
Main Results:
- Children on VPA showed significantly lower mean copper (Cu) levels at 6 months compared to controls.
- Thyroid-stimulating hormone (TSH) levels were significantly increased, while free thyroxine (FT4) levels were significantly decreased in the VPA group.
- A positive correlation was observed between Cu and T4 levels; changes in logCu and TSH were negatively correlated.
Conclusions:
- VPA therapy in children may lead to a reduction in serum copper levels.
- The observed alterations in thyroid hormone profile (increased TSH, decreased FT4) during VPA treatment might be associated with decreased serum copper concentrations.
- This suggests copper deficiency as a potential mechanism for VPA-induced thyroid dysfunction in pediatric patients.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...